Form 8-K - Current report:
SEC Accession No. 0000950170-24-139121
Filing Date
2024-12-20
Accepted
2024-12-20 17:00:08
Documents
11
Period of Report
2024-12-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K sndx-20241220.htm   iXBRL 8-K 37550
  Complete submission text file 0000950170-24-139121.txt   153267

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sndx-20241220.xsd EX-101.SCH 25828
13 EXTRACTED XBRL INSTANCE DOCUMENT sndx-20241220_htm.xml XML 4869
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

EIN.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 241568736
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)